Gene TherapyOncology Market

The global Gene Therapy in Oncology market size was valued at US$ 3.45 billion in 2024 and is projected to reach US$ 12.34 billion by 2030, at a CAGR of 23.6% during the forecast period 2024-2030.

United States Gene Therapy in Oncology market size was valued at US$ 1.12 billion in 2024 and is projected to reach US$ 3.87 billion by 2030, at a CAGR of 22.9% during the forecast period 2024-2030.

Therapeutic approach using genetic material to treat or prevent cancer.

Rapid growth driven by advancements in gene editing technologies and delivery methods. Increasing investment in cancer research and personalized medicine. Ongoing clinical trials for various cancer types showing promising results.

Report Overview

Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.

Gene TherapyOncology Market provides a deep insight into the global Gene Therapy in Oncology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Therapy in Oncology Market, Gene TherapyOncology Market introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, Gene TherapyOncology Market is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Therapy in Oncology market in any manner.

Global Gene Therapy in Oncology Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bristol-Myers Squibb

Cold Genesys

Advantagene

Amgen

AstraZeneca

Bio-Path Holdings

CRISPR Therapeutics

Editas Medicine

Geron Corp

Idera Pharmaceuticals

Intellia Therapeutics

Johnson & Johnson

Marsala Biotech

Merck

Mologen AG

Oncolytics Biotech

Oncosec

Oncotelic

Shenzhen SiBiono GeneTech

Sillajen Biotherapeutics

Tocagen

UniQure

Ziopharm Oncology

Market Segmentation (by Type)

Ex Vivo

In Vivo

Market Segmentation (by Application)

Hospitals

Diagnostics Centers

Research Institutes

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Gene Therapy in Oncology Market

Overview of the regional outlook of the Gene Therapy in Oncology Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter